Lapas attēli
PDF
ePub

KF26 G6443 1972

COMMITTEE ON GOVERNMENT OPERATIONS

JOHN L. MCCLELLAN, Arkansas, Chairman

[blocks in formation]

SUBCOMMITTEE ON EXECUTIVE REORGANIZATION AND GOVERNMENT RESEARCH
ABRAHAM RIBICOFF, Connecticut, Chairman

FRED R. HARRIS, Oklahoma

LEE METCALF, Montana
JAMES B. ALLEN, Alabama

HUBERT H. HUMPHREY, Minnesota

JACOB K. JAVITS, New York
CHARLES H. PERCY, Illinois

CHARLES McC. MATHIAS, JR., Maryland
KARL E. MUNDT, South Dakota

ROBERT WAGER, Staff Director and General Counsel
MARK E. GREENWOLD, Assistant General Counsel
GERRY SIMONS, Special Counsel

STUART M. STATLER, Minority Counsel
PAMELA J. GELL, Chief Clerk

(n)

[ocr errors][merged small]

Page

2. Statement of James S. Turner, Esq..

112

3. Statement of Arnold B. Elkind, Chairman, Commission on Product
Safety from March 1968 to September 1970.

116

No.

EXHIBITS-Continued

4. Statement of Dr. Leorard Hayflick, professor, Stanford University School of Medicine, Stanford, Calif

5. Statement by Rodney E. Leonard, Executive Director, Community Nutrition Institute..

6. Statement of Judy Jackson, Public Interest Research Group, and a section-by-section research analysis of S. 3419 submitted for the

record

7. Table setting forth budget authority for certain Federal regulatory
agencies, submitted for the record by Secretary Richardson
8. "Responsibility and Responsiveness,' the HEW potential for the
seventies, submitted for the record by Secretary Richardson...-
9. "Notice of Proposed Rulemaking on Natural or Unavoidable Defects
in Food for Human use That Presents No Health Hazard," Depart-
ment of Health, Education, and Welfare-Food and Drug Adminis-
tration, 21 CFR part 128-

10. Request for information from Senator Percy to Secretary of Health,
Education, and Welfare, March 29, 1972, and the material subse-
quently submitted for the record.

11. Lead Christmas tinsel agreement supplied for the record by HEW at the request of Senator Percy-.

12. Letter and questions from Senator Javits to Secretary Richardson, May 3, 1972, and the response subsequently submitted for the record, June 2, 1972...

13. Statement of Secretary Richardson on the transfer of DBS to FDA..
14. Assistance provided to the Food and Drug Administration by the
National Bureau of Standards, 1970–72.

15. Exchange of correspondence between HEW and the Department of
Commerce relevant to the possibility of NBS assisting the Consumer
Safety Agency in testing and establishing standards for products...
16. Resources for FDA by program category-1972 and 1973__.
17. Material submitted for the record on the Ash Council report by OMB
at the request of Senator Percy..

18. Response as to whether OMB would support Secretary Richardson
in striking the balance in the authority to be given to the Assistant
Secretary, if it is created within HEW.

19. Food and Drug Administration budget history submitted for the record by OMB...

20. OMB comments on statement of Secretary Richardson regarding conduct of litigation by FDA attorneys.

21. OMB response to question from Senator Percy regarding what percentage of cases recommended for prosecution by FDA has Justice refused to prosecute_

Page

119

127

160

202

203

237

244

302

303

308

309

310

312

351

352

352

353

353

22. Further OMB comments on administrative provisions of S. 3419... 23. GAO reports relating to consumer product safety issued since March 1968..

354

24. Statement of Peter Isacson, associate professor of social and preventive medicine, project director of the Vaccine Evaluation Unit, State University of New York, Buffalo, N. Y..

356

374

25. Statement by George P. Shultz, Director, Office of Management and budget...

378

26. Statement of the National Consumers League, submitted by Alice Shabecoff, executive director, May 3, 1972_.

380

27. Statement of Communications and Industrial Electronics Division

381

383

of Electronic Industries Association submitted by Richard E. Horner. 28. Statement of George P. Lamb, general counsel, on behalf of the Association of Home Appliance Manufacturers-

29. Statement of the Parts Division, Solid State Products Division,
Tube Division of the Electronic Industries Association...............
30. Statement by J. Garrott Allen, M.D., professor of surgery, Stanford
University Medical Center, Stanford, Calif., May 8, 1972
31. "Some Features of the Blood-Service Complex in New Jersey" by
Martin Goldfield, M.D., and Federico Colosimo, B.A., from the
Division of Laboratories and Epidemiology, New Jersey State
Department of Health...

388

390

404

No.

EXHIBITS-Continued

32. Letter from E. B. Mayo, Jr., of the American Council of Independent
Laboratories, Inc., to Robert J. Wager, Esq., general counsel of
Subcommittee on Executive Reorganization and Government
Research, dated April 20, 1972__

33. Letter from Erma Angevine, executive director of Consumer Federa-
tion of America, to Senator Fred R. Harris, dated April 21, 1972_
34. Letter from Antonie T. Knoppers of Merk & Co., Inc., to Senator
Abraham A. Ribicoff, dated April 26, 1972_-

35. Letter from Leonard Hayflick, Ph. D., of Stanford University, to Antonie T. Knoppers, M.D., of Merck & Co., Inc., dated May 2, 197236. Letter from Wilbur J. Cohen, dean, University of Michigan, to Senator Gaylord Nelson, dated April 29, 1972.

37. Letter from Stanley A. Plotkin, associate professor of pediatrics, University of Pennsylvania, to Senator Ribicoff, dated May 1, 1972 38. Letter from C. Henry Kempe, M.D., professor and chairman, Department of Pediatrics, University of Colorado Medical Center, to Senator Ribicoff, dated May 3, 1972..

39. Letter from Walter S. Lewis, Jr., of Gas Manufacturer Association, to Senator Ribicoff, dated May 3, 1972---

Page

414

415

416

417

418

419

421

421

40. Letter from Hilton Davis, of Chamber of Commerce of the United
States, to Senator Ribicoff dated May 10, 1972, and accompanying
statement submitted for the record..

41. Press release by Senator Ribicoff dated March 30, 1972, and the text of
speech regarding effectiveness of vaccines..
42. Report to the Subcommittee on Executive Reorganization and Govern-
ment Research, Committee on Government Operations, U.S.
Senate, entitled "Problems Involving the Effectiveness of Vaccines"
by the Comptroller General of the United States.

43. Memorandum from J. E. Smadal, M.D., Chief, LVR, DBS, to J.A.
Morris, Ph. D., chief, SRV, LVR, dated September 18, 1962----
44. Memorandum from Division of Public Health Grants and Services,
Office of the General Counsel-HEW to Dr. Roderick Murray,
Director, Division of Biologics Standards, dated February 28, 1969,
and accompanying material submitted for the record__
45. Memorandum from Director, Division of Biologics Standards, to
Director, Office of Legislative Analysis, dated July 30, 1969, and
accompanying material submitted for the record..

46. Memorandum from Edward J. Rourke, Assistant General Counsel, to
Dr. Luther L. Terry, Surgeon General, dated February 21, 1963---
47. Memorandum from Director, Division of Biologics Standards, to
Director, Office of Legislative Analysis, OD, dated November 19,
1969__

424

429

436

473

474

479

482

483

48. Memorandum from Head, Immunoserology Unit, LVR, to Director, DBS, through: Chief, LVR, dated July 12, 1968.

485

49. National Institutes of Health report on review of managerial and
personnel conditions in the Division of Biologics Standards_--
50. "Division of Biologics Standards: In the Matter of J. Anthony Morris,"
reprinted from Science, February 25, 1972-

486

491

51. "Division of Biologics Standards: Scientific Management Questioned," reprinted from Science, March 3, 1972.

498

52. "DBS: Officials Confused Over Powers," reprinted from Science, March 10, 1972_...

503

53. "Division of Biologics Standards: The Boat That Never Rocked," reprinted from Science, March 17, 1972

504

54 "DBS: Agency Contravenes Its Own Regulations," reprinted from Science, April 7, 1972__

55. "Vaccine Safety," from the Congressional Record, October 15, 1971__ 56. "Vaccine Regulation," from the Congressional Record, December 8, 1971, the documents supplied by HEW, and Morris-Turner analysis_ 57. Comments on Morris and Turner "rebuttal" to ad hoc committee report on DBS scientific management...

58. Memorandum to Dr. Robert Q. Marston, Director, National Institutes of Health, from James S. Turner and Dr. J. Anthony Morris regarding the scientific mismanagement at DBS, May 10, 1972__

[blocks in formation]

EXHIBITS-Continued

« iepriekšējāTurpināt »